Across the most recent 6 stories covering Temasek — 83% positive, 17% neutral sentiment, averaging 7.2/10 impact.
This entity profile aggregates every story where the entity meets our minimum relevance
threshold before it is linked here — a story naming this entity only in passing, as
competitive context for an unrelated subject, does not qualify. That threshold exists
because earlier testing surfaced entity pages cluttered with tangential mentions: a story
about two unrelated companies merging could otherwise populate a third company's page
simply because it was named once for comparison, with no real event of its own. The
timeline below reflects genuine milestones and developments specific to this entity,
cross-referenced against the same source-verification standard applied to every story on
this site. Sentiment measures the directional read of each development for this entity
specifically, not the overall tone of the reporting, and impact weights how consequential
a development is rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and
sentiment are derived.
Timeline
Manipal integrates acquisitions of Columbia Asia and AMRI Hospitals to expand its footprint.
Manipal Health officially files the Draft Red Herring Prospectus (DRHP) for an $852M IPO.
Advisory Team Finalized
NSE officially appoints 20 bankers and 8 law firms to manage the $2.5B offering.
Unicorn Funding Pursuit
Reports emerge of a $200M raise to achieve a $1B valuation and scale orbital missions.
Regulatory Clearance
SEBI signals a 'no-objection' for the IPO following governance improvements.
Series C Funding
Raised $51 million led by GIC to scale up launch vehicle development.
Temasek Majority Stake
Temasek acquires a majority stake in Manipal Health, valuing the company at $5 billion.
Vikram-S Launch
Successfully launched India's first privately developed rocket into sub-orbital space.
SEBI Disciplinary Action
SEBI passes orders in the co-location case, stalling the IPO process.
Company Founded
Skyroot Aerospace founded by former ISRO scientists Pawan Kumar Chandana and Naga Bharath Daka.
First DRHP Filed
NSE files its first draft prospectus for a public listing.
Manipal Health Enterprises has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI, marking a significant milestone for the Temasek-backed hospital chain. The IPO is expected to be one of the largest in the Indian healthcare sector, providing a partial exit for institutional investors while fueling further expansion.
Manipal Health Enterprises, one of India's largest multi-specialty healthcare chains, has officially filed for an initial public offering seeking to raise approximately $852 million. The move represents a significant liquidity event for majority shareholder Temasek and signals a robust appetite for healthcare infrastructure in the Indian public markets.
The National Stock Exchange of India has appointed 20 merchant bankers and eight law firms to manage its highly anticipated initial public offering. This move signals a definitive step toward a $2.5 billion market debut, marking the end of a decade-long regulatory wait for the world's largest derivatives exchange.
AI pioneer Yann LeCun has raised $1.03 billion for his new startup, AMI Labs, to develop 'world models' that aim to surpass the reasoning capabilities of current LLMs. Backed by Nvidia and Temasek, the round represents the largest seed investment in European history and a major bet on alternative AI architectures.
Former Meta AI chief Yann LeCun has raised $1.03 billion for his new venture, AMI (Advanced Machine Intelligence Labs), to develop an alternative to current Large Language Model architectures. The record-breaking seed round, valuing the company at $3.5 billion, focuses on 'world models' designed to overcome the reasoning and physical understanding limitations of existing AI.
Hyderabad-based Skyroot Aerospace is seeking to raise between $150 million and $200 million to accelerate its commercial launch capabilities and global expansion. The funding round, which could value the company at nearly $1 billion, would cement Skyroot's position as the leader in India's rapidly maturing private space sector.
This page surfaces every story mentioning Temasek across our startup coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running startup beat. Cross-entity comparisons live on our compare view.
Entities only appear on this page once the classifier scores them at a minimum 35 percent
relevance to the story, filtering out passing mentions. According to that methodology,
reviewed July 2026, this follows multi-source corroboration standards recommended by
journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
What you see
What it tells you
Story count
Number of distinct stories where Temasek was a primary or referenced actor.
Recency clustering
Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distribution
Aggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche links
When the same entity surfaces in our sibling networks, we link to those views to enrich context.